Viewing nowCombinationTuberol Tablets 120/20 milligrams
Fimasartan Potassium Trihydrate Granules 300mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.

MFDS item code 201605335 · Approved 2016.08.31
Treatment of hypertension and dyslipidemia; inhibits the progression of atherosclerosis and prevents cardiovascular disease
This medication is used for patients who need to take both Pimasartan and Rosuvastatin concurrently. Pimasartan primarily helps in controlling blood pressure in patients with essential hypertension. Rosuvastatin acts as an adjunct to dietary therapy in patients with hypercholesterolemia and hyperlipidemia, lowering blood cholesterol and LDL-cholesterol levels, which helps delay the progression of atherosclerosis. Additionally, it reduces the risk of cardiovascular diseases, preventing complications that can arise after strokes, myocardial infarctions, or arterial revascularization procedures. Thus, this medication is effectively used in the treatment of patients with both hypertension and dyslipidemia.
This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, fimasartan and rosuvastatin. ○ Fimasartan 1. Adults The recommended dose of this medicine is 30~60 mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, the dose may be increased to 120 mg once daily. If possible, it is recommended that the medicine be taken at the same time each day (e.g., in the morning). The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks~12 weeks. 2. Older adults No initial dose adjustment is required in older adults aged 70 years or younger. (Refer to section 9. Administration to Older Adults under Precautions for Use.) 3. Patients with renal impairment No dose adjustment is required in patients with mild~moderate renal impairment (creatinine clearance 30~80 mL/min). In patients with severe renal impairment (creatinine clearance < 30 mL/min), however, treatment should be initiated at 30 mg once daily, and the dose should not exceed 60 mg per day. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. This medicine should not be administered to patients with moderate~severe hepatic impairment. (Refer to sections 2. Patients Who Must Not Be Treated with This Medicine and 10. Administration to Patients with Hepatic Impairment under Precautions for Use.) 5. Patients with reduced effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with reduced effective circulating blood volume, an initial dose of 30 mg once daily is recommended. (Refer to section 3. Administration with Caution under Precautions for Use.) ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased up to a maximum of 20 mg per day. 2. Older adults No dose adjustment is required. 3. Patients with renal impairment No dose adjustment is required in patients with mild or moderate renal impairment. This medicine should not be administered to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment Systemic exposure to rosuvastatin did not increase in patients with a Child-Pugh score of 7 or less, but it increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. This medicine should not be administered to patients with active liver disease. 5. Race Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients. Patients taking fimasartan and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience of administration.
This medication may cause serious harm or death to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to the ingredients in this medication, pregnant or breastfeeding women, or women of childbearing age who are not using adequate contraception should not take this medication. Patients with severe liver dysfunction, very poor kidney function, or certain muscle diseases should also avoid using this medication. Patients with low blood volume or reduced sodium levels, weak kidney function, or issues related to the heart or blood vessels should exercise caution when taking this medication and need to be closely monitored. This medication can affect the liver and muscles, so patients with a history of liver disease or symptoms of muscle pain or weakness should inform their healthcare providers immediately. Additionally, this medication contains certain pigments that may cause allergic reactions in susceptible individuals. During treatment, side effects such as dizziness, headache, indigestion, nausea, fever, liver function abnormalities, and muscle pain may occur, so it's important to consult healthcare professionals if any symptoms develop. Caution is advised during driving or machinery operation as drowsiness or dizziness may occur. This medication can interact with other drugs, so inform healthcare providers of all other medications being taken. Women who are pregnant or are planning to become pregnant should not take this medication, and it is also advisable to avoid it while breastfeeding. Children under 18 years of age and elderly patients over 70 years require special attention while using this medication, and those with weak liver and kidney function may need dosage adjustments. In case of overdose, symptoms such as hypotension, heart palpitations, and bradycardia may occur, so immediate medical assistance should be sought if symptoms arise. This medication should be kept out of the reach of children and should not be transferred to other containers for safety.
Dyspepsia, nausea, fever, hepatitis, headache, dizziness, syncope, sedation, migraine, vomiting, abdominal pain, malaise, foreign body sensation, elevated ALT, elevated γ-GTP, elevated liver enzyme levels, increased white blood cell count, urinary disorders, frequent urination, cough, hyperkalemia, arthralgia, insomnia, pruritus, angioedema, decreased platelet count, increased serum creatine phosphokinase, muscle contraction, muscular rigidity, localized urticaria, facial flushing, erythema, erectile dysfunction, constipation, abdominal pain, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, malaise, polyneuropathy, memory loss, peripheral neuropathy, diarrhea, thrombocytopenia, jaundice, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe muscular weakness, ocular myasthenia, contusion, hypotension, palpitations, bradycardia, numbness, paresthesia, tremor, hypertonia, anxiety, memory impairment, loss of appetite, gastroesophageal reflux, gastritis, functional gastrointestinal disorders, gastroenteritis, urinary incontinence, dysuria, hyperlipidemia, dyslipidemia, hypoglycemia, chest pain, low back pain, limb pain, facial edema, fatigue, fever, neck/shoulder pain, fracture, osteoporosis, pharyngitis, upper respiratory infection, epistaxis, bronchitis, paresthesia, numbness, tremor, spinal canal stenosis, insomnia, depression, anxiety, memory impairment, loss of appetite, gastroesophageal reflux, gastritis, diarrhea, constipation, functional gastrointestinal disorders, gastroenteritis, frequent urination, urinary incontinence, kidney stones, chronic renal failure, dysuria, hypercholesterolemia, diabetes, hypertriglyceridemia, thirst, worsening of diabetes, calcinosis, hyponatremia, gout, eye pain, retinal disease, glaucoma, cataract, diplopia, floaters, uveitis, visual disturbances, retinal disease, floaters, worsening of chronic renal failure, cystitis, urinary tract infection, increased BUN, acute renal failure, pyelonephritis, otitis media, fungal infection, abscess, bacterial infection, genital herpes, cold sores, shingles, colorectal carcinoma, neoplasm unspecified, liver cancer, cervical cancer, prostate cancer, thrombocytosis, panic response, Alzheimer's disease, suicide attempt, agitation, hyperthyroidism, hypothyroidism, increased TSH, benign pituitary neoplasm, atrial fibrillation, bradycardia, arrhythmia, ventricular arrhythmia, tachycardia, coronary artery disease, arterial stenosis, aortic stenosis, angina pectoris, myeloproliferative disease, worsened anemia, iron deficiency anemia, tinnitus, hearing impairment, deafness, pelvic inflammatory disease, vaginitis, uterine prolapse, benign prostatic hyperplasia, scrotal pain, blood pressure fluctuations, fatty liver, localized inflammation, soft tissue infection, lymphadenopathy, wound, septal deviation, postoperative pain, heat intolerance, recurrent cancer, fall, postoperative pain, chills, nasal polyps, edema, peripheral edema, facial edema, fatigue, fever, syncope, generalized pain, muscle cramps, gout, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it is safe to store it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication and prevent degradation.
Orange oval film-coated tablet
30 tablets/box [10 tablets/PTP packaging × 3], 100 tablets/box [10 tablets/PTP packaging × 10], 30 tablets/box [10 tablets/Alu-Alu packaging × 3], 100 tablets/box [10 tablets/Alu-Alu packaging × 10]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate Granules 300mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 75mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 75mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Fimasartan Potassium Trihydrate Granules 75mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Fimasartan Potassium Trihydrate Granules 75mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Fimasartan Potassium Trihydrate Granules 150mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.